{"id":33494,"date":"2022-07-19T12:00:00","date_gmt":"2022-07-19T12:00:00","guid":{"rendered":"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/"},"modified":"2022-07-19T12:00:00","modified_gmt":"2022-07-19T12:00:00","slug":"la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea","status":"publish","type":"news","link":"https:\/\/www.euforea.org\/fr\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/","title":{"rendered":"La revue \u00ab Frontiers in Allergy \u00bb et le succ\u00e8s des nouvelles recommandations EUFOREA"},"content":{"rendered":"<div class=\"paragraph paragraph--text-columns paragraph-id--1853 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<p>La revue \u00ab Frontiers in Allergy \u00bb est une revue m\u00e9dicale innovante et de haut impact qui traite des m\u00e9canismes et des \u00e9tiologies de l&#8217;allergie dans diff\u00e9rents organes. Elle se concentre \u00e9galement sur la prise en charge des maladies allergiques dans toutes les tranches d&#8217;\u00e2ge, de l&#8217;enfance \u00e0 l&#8217;\u00e2ge adulte. <\/p>\n<p>La prise en charge des allergies et des maladies allergiques repr\u00e9sente un d\u00e9fi soci\u00e9tal en raison du nombre croissant de patients souffrant de pathologies d&#8217;hypersensibilit\u00e9. Les maladies allergiques affectent de nombreux organes diff\u00e9rents et impliquent donc un large \u00e9ventail de sp\u00e9cialistes. Elles se pr\u00e9sentent \u00e9galement de mani\u00e8re tr\u00e8s diff\u00e9rente avec une grande diversit\u00e9 de ph\u00e9notypes allergiques. La sp\u00e9cialit\u00e9 \u00e9volue rapidement et la revue cherche \u00e0 communiquer les derni\u00e8res d\u00e9couvertes et recherches \u00e0 son public cible.   <\/p>\n<p>Nouvelles recommandations EUFOREA sur la rhinite allergique de l&#8217;enfance \u00e0 l&#8217;\u00e2ge adulte :<\/p>\n<ul>\n<li><a href=\"https:\/\/www.euforea.org\/fr\/news\/guide-de-poche-sur-la-rhinite-allergique-pediatrique\/\" target=\"_blank\" rel=\"noopener\"><strong>Guide de poche p\u00e9diatrique sur la rhinite allergique<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/www.euforea.org\/fr\/news\/guide-de-poche-sur-la-rhinite-allergique\/\" target=\"_blank\" rel=\"noopener\"><strong>Guide de poche adulte sur la rhinite allergique<\/strong><\/a><\/li>\n<li><a href=\"https:\/\/www.euforea.org\/fr\/news\/algorithme-therapeutique-deuforea-pour-la-rhinite-allergique\/\" target=\"_blank\" rel=\"noopener\"><strong>Algorithme de traitement de la rhinite allergique<\/strong><\/a><\/li>\n<\/ul>\n<p>Rejoignez le Pr Glenis Scadding (Royaume-Uni), membre du conseil d&#8217;administration d&#8217;EUFOREA et pr\u00e9sidente du panel EUFOREA sur la rhinite, professeure associ\u00e9e honoraire au d\u00e9partement d&#8217;infection et d&#8217;immunit\u00e9 de l&#8217;University College London Hospitals, et le Pr Nikos Papadopoulos (Gr\u00e8ce), professeur d&#8217;allergologie et d&#8217;allergie p\u00e9diatrique \u00e0 l&#8217;Universit\u00e9 de Manchester, professeur et chef du d\u00e9partement d&#8217;allergie p\u00e9diatrique \u00e0 l&#8217;Universit\u00e9 d&#8217;Ath\u00e8nes, et r\u00e9dacteur en chef de Frontiers in Allergy.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<div class=\"paragraph paragraph--text-columns paragraph-id--1854 paragraph--type--text-columns paragraph--view-mode--default clearfix paragraph--text-columns--1col\">\n<div class=\"inner--wide\">\n<div class=\"text__text text text--paragraph\">\n<div class=\"video-container\"><iframe title=\"Lecteur vid\u00e9o YouTube\" src=\"https:\/\/www.youtube.com\/embed\/j7fDhhhPRzg?rel=0\" width=\"560\" height=\"315\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>La revue \u00ab Frontiers in Allergy \u00bb est une revue m\u00e9dicale innovante et de haut impact qui traite des m\u00e9canismes et des \u00e9tiologies de l&#8217;allergie dans diff\u00e9rents organes. Elle se concentre \u00e9galement sur la prise en charge des maladies allergiques dans toutes les tranches d&#8217;\u00e2ge, de l&#8217;enfance \u00e0 l&#8217;\u00e2ge adulte. La prise en charge des allergies et des maladies allergiques repr\u00e9sente un d\u00e9fi soci\u00e9tal en raison du nombre croissant de patients souffrant de pathologies d&#8217;hypersensibilit\u00e9. Les maladies allergiques affectent de nombreux organes diff\u00e9rents et impliquent donc un large \u00e9ventail de sp\u00e9cialistes. Elles se pr\u00e9sentent \u00e9galement de mani\u00e8re tr\u00e8s diff\u00e9rente avec une grande diversit\u00e9 de ph\u00e9notypes allergiques. La sp\u00e9cialit\u00e9 \u00e9volue rapidement et la revue cherche \u00e0 communiquer les derni\u00e8res d\u00e9couvertes et recherches \u00e0 son public cible. Nouvelles recommandations EUFOREA sur la rhinite allergique de l&#8217;enfance \u00e0 l&#8217;\u00e2ge adulte : Guide de poche p\u00e9diatrique sur la rhinite allergique Guide de poche adulte sur la rhinite allergique Algorithme de traitement de la rhinite allergique Rejoignez le Pr Glenis Scadding (Royaume-Uni), membre du conseil d&#8217;administration d&#8217;EUFOREA et pr\u00e9sidente du panel EUFOREA sur la rhinite, professeure associ\u00e9e honoraire au d\u00e9partement d&#8217;infection et d&#8217;immunit\u00e9 de l&#8217;University College London Hospitals, et le Pr Nikos Papadopoulos (Gr\u00e8ce), professeur d&#8217;allergologie et d&#8217;allergie p\u00e9diatrique \u00e0 l&#8217;Universit\u00e9 de Manchester, professeur et chef du d\u00e9partement d&#8217;allergie p\u00e9diatrique \u00e0 l&#8217;Universit\u00e9 d&#8217;Ath\u00e8nes, et r\u00e9dacteur en chef de Frontiers in Allergy.<\/p>\n","protected":false},"author":1,"featured_media":33509,"comment_status":"open","ping_status":"closed","template":"","meta":{"footnotes":""},"categories":[169],"tags":[171,269,285],"class_list":["post-33494","news","type-news","status-publish","has-post-thumbnail","hentry","category-emissions-dactualite-euforea","tag-actualites-euforea","tag-rhinite-allergique-ra","tag-guides-de-poche"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.5 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>La revue \u00ab Frontiers in Allergy \u00bb et le succ\u00e8s des nouvelles recommandations EUFOREA - EUFOREA<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"La revue \u00ab Frontiers in Allergy \u00bb et le succ\u00e8s des nouvelles recommandations EUFOREA\" \/>\n<meta property=\"og:description\" content=\"La revue \u00ab Frontiers in Allergy \u00bb est une revue m\u00e9dicale innovante et de haut impact qui traite des m\u00e9canismes et des \u00e9tiologies de l&#8217;allergie dans diff\u00e9rents organes. Elle se concentre \u00e9galement sur la prise en charge des maladies allergiques dans toutes les tranches d&#8217;\u00e2ge, de l&#8217;enfance \u00e0 l&#8217;\u00e2ge adulte. La prise en charge des allergies et des maladies allergiques repr\u00e9sente un d\u00e9fi soci\u00e9tal en raison du nombre croissant de patients souffrant de pathologies d&#8217;hypersensibilit\u00e9. Les maladies allergiques affectent de nombreux organes diff\u00e9rents et impliquent donc un large \u00e9ventail de sp\u00e9cialistes. Elles se pr\u00e9sentent \u00e9galement de mani\u00e8re tr\u00e8s diff\u00e9rente avec une grande diversit\u00e9 de ph\u00e9notypes allergiques. La sp\u00e9cialit\u00e9 \u00e9volue rapidement et la revue cherche \u00e0 communiquer les derni\u00e8res d\u00e9couvertes et recherches \u00e0 son public cible. Nouvelles recommandations EUFOREA sur la rhinite allergique de l&#8217;enfance \u00e0 l&#8217;\u00e2ge adulte : Guide de poche p\u00e9diatrique sur la rhinite allergique Guide de poche adulte sur la rhinite allergique Algorithme de traitement de la rhinite allergique Rejoignez le Pr Glenis Scadding (Royaume-Uni), membre du conseil d&#8217;administration d&#8217;EUFOREA et pr\u00e9sidente du panel EUFOREA sur la rhinite, professeure associ\u00e9e honoraire au d\u00e9partement d&#8217;infection et d&#8217;immunit\u00e9 de l&#8217;University College London Hospitals, et le Pr Nikos Papadopoulos (Gr\u00e8ce), professeur d&#8217;allergologie et d&#8217;allergie p\u00e9diatrique \u00e0 l&#8217;Universit\u00e9 de Manchester, professeur et chef du d\u00e9partement d&#8217;allergie p\u00e9diatrique \u00e0 l&#8217;Universit\u00e9 d&#8217;Ath\u00e8nes, et r\u00e9dacteur en chef de Frontiers in Allergy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/\" \/>\n<meta property=\"og:site_name\" content=\"EUFOREA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/euforea\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@euforea\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\\\/\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\\\/\",\"name\":\"La revue \u00ab Frontiers in Allergy \u00bb et le succ\u00e8s des nouvelles recommandations EUFOREA - EUFOREA\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/27Frontiers20in20Allergy2720Journal20and20the20Success20of20EUFOREA20Novel20Guidelines_0.png\",\"datePublished\":\"2022-07-19T12:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.euforea.org\\\/news\\\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\\\/#primaryimage\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/27Frontiers20in20Allergy2720Journal20and20the20Success20of20EUFOREA20Novel20Guidelines_0.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/27Frontiers20in20Allergy2720Journal20and20the20Success20of20EUFOREA20Novel20Guidelines_0.png\",\"width\":1280,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/fr\\\/choisissez-votre-parcours\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/www.euforea.org\\\/news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"La revue \u00ab Frontiers in Allergy \u00bb et le succ\u00e8s des nouvelles recommandations EUFOREA\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#website\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"name\":\"EUFOREA\",\"description\":\"Inspiring the Future of Respiratory Care\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.euforea.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#organization\",\"name\":\"EUFOREA\",\"url\":\"https:\\\/\\\/www.euforea.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"contentUrl\":\"https:\\\/\\\/s3.nl-ams.scw.cloud\\\/euforea-wp-production\\\/uploads\\\/euforea.png\",\"width\":500,\"height\":500,\"caption\":\"EUFOREA\"},\"image\":{\"@id\":\"https:\\\/\\\/www.euforea.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/euforea\\\/\",\"https:\\\/\\\/x.com\\\/euforea\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/euforea\",\"https:\\\/\\\/www.youtube.com\\\/c\\\/EUFOREA\",\"https:\\\/\\\/www.instagram.com\\\/euforeaofficial\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"La revue \u00ab Frontiers in Allergy \u00bb et le succ\u00e8s des nouvelles recommandations EUFOREA - EUFOREA","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/","og_locale":"fr_FR","og_type":"article","og_title":"La revue \u00ab Frontiers in Allergy \u00bb et le succ\u00e8s des nouvelles recommandations EUFOREA","og_description":"La revue \u00ab Frontiers in Allergy \u00bb est une revue m\u00e9dicale innovante et de haut impact qui traite des m\u00e9canismes et des \u00e9tiologies de l&#8217;allergie dans diff\u00e9rents organes. Elle se concentre \u00e9galement sur la prise en charge des maladies allergiques dans toutes les tranches d&#8217;\u00e2ge, de l&#8217;enfance \u00e0 l&#8217;\u00e2ge adulte. La prise en charge des allergies et des maladies allergiques repr\u00e9sente un d\u00e9fi soci\u00e9tal en raison du nombre croissant de patients souffrant de pathologies d&#8217;hypersensibilit\u00e9. Les maladies allergiques affectent de nombreux organes diff\u00e9rents et impliquent donc un large \u00e9ventail de sp\u00e9cialistes. Elles se pr\u00e9sentent \u00e9galement de mani\u00e8re tr\u00e8s diff\u00e9rente avec une grande diversit\u00e9 de ph\u00e9notypes allergiques. La sp\u00e9cialit\u00e9 \u00e9volue rapidement et la revue cherche \u00e0 communiquer les derni\u00e8res d\u00e9couvertes et recherches \u00e0 son public cible. Nouvelles recommandations EUFOREA sur la rhinite allergique de l&#8217;enfance \u00e0 l&#8217;\u00e2ge adulte : Guide de poche p\u00e9diatrique sur la rhinite allergique Guide de poche adulte sur la rhinite allergique Algorithme de traitement de la rhinite allergique Rejoignez le Pr Glenis Scadding (Royaume-Uni), membre du conseil d&#8217;administration d&#8217;EUFOREA et pr\u00e9sidente du panel EUFOREA sur la rhinite, professeure associ\u00e9e honoraire au d\u00e9partement d&#8217;infection et d&#8217;immunit\u00e9 de l&#8217;University College London Hospitals, et le Pr Nikos Papadopoulos (Gr\u00e8ce), professeur d&#8217;allergologie et d&#8217;allergie p\u00e9diatrique \u00e0 l&#8217;Universit\u00e9 de Manchester, professeur et chef du d\u00e9partement d&#8217;allergie p\u00e9diatrique \u00e0 l&#8217;Universit\u00e9 d&#8217;Ath\u00e8nes, et r\u00e9dacteur en chef de Frontiers in Allergy.","og_url":"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/","og_site_name":"EUFOREA","article_publisher":"https:\/\/www.facebook.com\/euforea\/","twitter_card":"summary_large_image","twitter_site":"@euforea","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/","url":"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/","name":"La revue \u00ab Frontiers in Allergy \u00bb et le succ\u00e8s des nouvelles recommandations EUFOREA - EUFOREA","isPartOf":{"@id":"https:\/\/www.euforea.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/#primaryimage"},"image":{"@id":"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/#primaryimage"},"thumbnailUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/27Frontiers20in20Allergy2720Journal20and20the20Success20of20EUFOREA20Novel20Guidelines_0.png","datePublished":"2022-07-19T12:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/#primaryimage","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/27Frontiers20in20Allergy2720Journal20and20the20Success20of20EUFOREA20Novel20Guidelines_0.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/27Frontiers20in20Allergy2720Journal20and20the20Success20of20EUFOREA20Novel20Guidelines_0.png","width":1280,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/www.euforea.org\/news\/la-revue-frontiers-in-allergy-et-le-succes-des-nouvelles-recommandations-euforea\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.euforea.org\/fr\/choisissez-votre-parcours\/"},{"@type":"ListItem","position":2,"name":"News","item":"https:\/\/www.euforea.org\/news\/"},{"@type":"ListItem","position":3,"name":"La revue \u00ab Frontiers in Allergy \u00bb et le succ\u00e8s des nouvelles recommandations EUFOREA"}]},{"@type":"WebSite","@id":"https:\/\/www.euforea.org\/#website","url":"https:\/\/www.euforea.org\/","name":"EUFOREA","description":"Inspiring the Future of Respiratory Care","publisher":{"@id":"https:\/\/www.euforea.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.euforea.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.euforea.org\/#organization","name":"EUFOREA","url":"https:\/\/www.euforea.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/","url":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","contentUrl":"https:\/\/s3.nl-ams.scw.cloud\/euforea-wp-production\/uploads\/euforea.png","width":500,"height":500,"caption":"EUFOREA"},"image":{"@id":"https:\/\/www.euforea.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/euforea\/","https:\/\/x.com\/euforea","https:\/\/www.linkedin.com\/company\/euforea","https:\/\/www.youtube.com\/c\/EUFOREA","https:\/\/www.instagram.com\/euforeaofficial\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/33494","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"author":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/comments?post=33494"}],"version-history":[{"count":0,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/news\/33494\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media\/33509"}],"wp:attachment":[{"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/media?parent=33494"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/categories?post=33494"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euforea.org\/fr\/wp-json\/wp\/v2\/tags?post=33494"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}